Status:
UNKNOWN
Gliogene: Brain Tumor Linkage Study
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Brain Tumor
Glioma
Eligibility:
All Genders
Brief Summary
The goal of this research study is to investigate the role of genes that may point to a higher risk of developing a glioma. Researchers will use new gene mapping techniques to study how high-risk fact...
Detailed Description
A consortium (group) of researchers wants to learn more about gliomas as well as the risk factors (such as environmental and genetic information) for patients with this kind of brain tumor. Participan...
Eligibility Criteria
Inclusion
- 1\) An affected or unaffected member of a family that has two or more reported gliomas (ICD9 codes 191.0-191.9) in the family.
Exclusion
- N/A
Key Trial Info
Start Date :
February 12 2004
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2022
Estimated Enrollment :
17080 Patients enrolled
Trial Details
Trial ID
NCT00418899
Start Date
February 12 2004
End Date
September 1 2022
Last Update
December 31 2020
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California Medical Center, San Francisco
San Francisco, California, United States, 94143
2
Moffitt Cancer Center
Tampa, Florida, United States, 33612
3
University of Illinois Medical Center, Chicago
Chicago, Illinois, United States, 60612
4
Evanston NW Healthcare
Evanston, Illinois, United States, 60201